Emilio Peña Ros

Dr. Emilio Peña Ros

Hospital Reina Sofía de Murcia, Murcia, Spain
+1
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 October 2015 in Techniques in Coloproctology
Verified
Journal Article
Closed access
PDF file
EREmilio Peña Ros
Emilio Peña Ros
PBP. A. Parra Baños
P. A. Parra Baños
JBJ. A. Benavides Buleje
J. A. Benavides Buleje
JCJ. M. Muñoz Camarena
J. M. Muñoz Camarena
CSC. Escamilla Segade
C. Escamilla Segade
AMA. Albarracín Marín-Blázquez
A. Albarracín Marín-Blázquez

26 July 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
JBJorge Alejandro Benavides-Buleje
Jorge Alejandro Benavides-Buleje
PFPedro Vicente Fernández-Fernández
Pedro Vicente Fernández-Fernández
ELENA RUIZ UCARELENA RUIZ UCAR
ELENA RUIZ UCAR
ASAMPARO SOLANA
AMPARO SOLANA
PPPedro Antonio Parra-Baños
Pedro Antonio Parra-Baños
AAAntonio Albarracín-Marín-Blázquez
Antonio Albarracín-Marín-Blázquez
(1) Background: For normo-nourished colorectal cancer patients, the need for immunonutrients after elective surgery is not known. (2) Methods: Multicenter, randomized, double-blind, phase III clinical trial comparing the postoperative diet with 200 mL oligomeric hyperproteic normocaloric (OHN; experimental arm) supplement vs. 200 mL immunonutritional (IN) (active comparator) supplement twice a day for five days in 151 normo-nourished adult colorectal-resection patients following the multimodal rehabilitation ERAS protocol. The proportions of patients with complications (primary outcome) and those who were readmitted, hospitalized for <7 days, had surgical site infections, or died due to surgical complications (secondary outcome) were compared between the two groups until postoperative day 30. Tolerance to both types of supplement and blood parameters was also assessed until day 5. (3) Results: Mean age was 69.2 and 84 (58.7%) were men. Complications were reported in 41 (28.7%) patients and the incidence did not differ between groups (18 (25%) vs. 23 (32.4%) patients with OHN and IN supplement, respectively; p = 0.328). No significant differences were found for the rest of the variables. (4) Conclusions: IN supplement may not be necessary for the postoperative recovery of colorectal cancer patients under the ERAS regimen and with normal nutritional status at the time of surgery.

27 June 2023 in Surgery
Verified
Journal Article
Closed access
JOJuan Ocaña
Juan Ocaña
JGJuan Carlos García-Pérez
Juan Carlos García-Pérez
DFDaniel Fernández-Martínez
Daniel Fernández-Martínez
IAIgnacio Aguirre
Ignacio Aguirre
IPIsabel Pascual
Isabel Pascual
JLJavier López-Ruiz
Javier López-Ruiz

1 December 2016 in Cirugía Española
Verified
Journal Article
Closed access
NSNuria Martinez Sanz
Nuria Martinez Sanz
EREmilio Peña Ros
Emilio Peña Ros
ACAngela Sánchez Cifuentes
Angela Sánchez Cifuentes
JBJorge Alejandro Benavides Buleje
Jorge Alejandro Benavides Buleje
AMAntonio Albarracín Marín-Blazquez
Antonio Albarracín Marín-Blazquez

28 February 2013 in Cirugía Española
Verified
Journal Article
Closed access
EREmilio Peña Ros
Emilio Peña Ros
MAMari Fe Candel Aremas
Mari Fe Candel Aremas
PPPatricia Pastor Pérez
Patricia Pastor Pérez
AMAntonio Albarracín Marín-Blázquez
Antonio Albarracín Marín-Blázquez

1 December 2014 in Cirugía Española
Verified
Journal Article
Closed access
EREmilio Peña Ros
Emilio Peña Ros
FMFrancisco Javier Ródenas Moncada
Francisco Javier Ródenas Moncada
ÁCÁngela Sánchez Cifuentes
Ángela Sánchez Cifuentes
AMAntonio Albarracín Marín-Blázquez
Antonio Albarracín Marín-Blázquez